CD8A and viral infectious disease: Moreover, the recent failure of the CD8 T cell–based Merck “STEP” vaccine trial in human HIV infection has alerted the community and has sparked renewed interest in complementary mechanisms that may aid immune defenses against persistent viral disease [16].